.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

PROSCAR Drug Profile

« Back to Dashboard
Proscar is a drug marketed by Merck and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has six patent family members in five countries.

The generic ingredient in PROSCAR is finasteride. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the finasteride profile page.

Summary for Tradename: PROSCAR

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1

Pharmacology for Tradename: PROSCAR

Clinical Trials for: PROSCAR

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
PROSCAR
finasteride
TABLET;ORAL020180-001Jun 19, 1992RXYes5,942,519<disabled> <disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROSCAR

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
PROSCAR
finasteride
TABLET;ORAL020180-001Jun 19, 19926,046,183<disabled>
Merck
PROSCAR
finasteride
TABLET;ORAL020180-001Jun 19, 19924,377,584<disabled>
Merck
PROSCAR
finasteride
TABLET;ORAL020180-001Jun 19, 19925,886,184<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: PROSCAR

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)9921563<disabled in preview>
Japan2001521000<disabled in preview>
Australia1279099<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc